DOCSLIB.ORG

Abnormal Methylation Characteristics Predict Chemoresistance and Poor Prognosis in Advanced High-Grade Serous Ovarian Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abnormal Methylation Characteristics Predict Chemoresistance and Poor Prognosis in Advanced High-Grade Serous Ovarian Cancer Feng et al. Clin Epigenet (2021) 13:141 https://doi.org/10.1186/s13148-021-01133-2 RESEARCH Open Access Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer Li‑yuan Feng , Bing‑bing Yan, Yong‑zhi Huang and Li Li* Abstract Background: Primary or acquired chemoresistance is a key link in the high mortality rate of ovarian cancer. There is no reliable method to predict chemoresistance in ovarian cancer. We hypothesized that specifc methylation charac‑ teristics could distinguish chemoresistant and chemosensitive ovarian cancer patients. Methods: In this study, we used 450 K Infnium Methylation BeadChip to detect the diferent methylation CpGs between ovarian cancer patients. The diferential methylation genes were analyzed by GO and KEGG Pathway bioin‑ formatics analysis. The candidate CpGs were confrmed by pyrosequencing. The expression of abnormal methylation gene was identifed by QRT‑PCR and IHC. ROC analysis confrmed the ability to predict chemotherapy outcomes. Prognosis was evaluated using Kaplan–Meier. Results: In advanced high‑grade serous ovarian cancer, 8 CpGs (ITGB6:cg21105318, cg07896068, cg18437633; NCALD: cg27637873, cg26782361, cg16265707; LAMA3: cg20937934, cg13270625) remained hypermethylated in chemoresistant patients. The sensitivity, specifcity and AUC of 8 CpGs (ITGB6:cg21105318, cg07896068, cg18437633; NCALD: cg27637873, cg26782361, cg16265707; LAMA3: cg20937934, cg13270625) methylation to predict chemo‑ therapy sensitivity were 63.60–97.00%, 46.40–89.30% and 0.774–0.846. PFS of 6 candidate genes (ITGB6:cg21105318, cg07896068; NCALD: cg27637873, cg26782361, cg16265707; LAMA3: cg20937934) hypermethylation patients was signifcantly shorter. The expression of NCALD and LAMA3 in chemoresistant patients was lower than that of chemo‑ sensitive patients. Spearman analysis showed that NCALD and LAMA3 methylations were negatively correlated with their expression. Conclusions: As a new biomarker of chemotherapy sensitivity, hypermethylation of NCALD and LAMA3 is associated with poor PFS in advanced high‑grade serous ovarian cancer. In the future, further research on NCALD and LAMA3 will be needed to provide guidance for clinical stratifcation of demethylation therapy. Keywords: Ovarian cancer, Chemotherapy resistance, DNA methylation, 450 K Infnium Methylation BeadChip, Prognosis Background Ovarian cancer is the most lethal cancer of the female reproductive system. In 2019, 22,530 new cases and 13,980 death occurred in the USA [1]. For the frst diag- *Correspondence: [email protected] Department of Gynecology and Oncology, Guangxi Medical University nosis of ovarian cancer patients, the standard treatment Cancer Hospital and Key Laboratory of Early Prevention and Treatment is the optimal surgical cytoreduction combined with plat- for Regional High Frequency Tumor, Ministry of Education, 71 Hedi Road, inum-based chemotherapy [2]. In the past decade, the Nanning 530021, Guangxi, People’s Republic of China survival rate of ovarian cancer has changed only a little, © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Feng et al. Clin Epigenet (2021) 13:141 Page 2 of 18 and the 5-year survival rate has remained below 30% [3, pathological diagnosis. All patients provided written 4]. Primary or acquired chemoresistance is a key link informed consent and were approved by the institutional in the high mortality rate of ovarian cancer [5, 6]. If the review committee of Guangxi Medical University Cancer patient’s sensitivity to traditional chemotherapy can be Hospital. assessed before treatment, doctors can guide chemore- sistant patients to undergo clinical trials to seek survival opportunities. Terefore, it is necessary to use robust and Follow‑up sensitive biomarkers to predict chemotherapy outcome OS (overall survival) was defned as the time from the in ovarian cancer patients. diagnosis to the death from ovarian cancer, and the sur- At present, there is no reliable method to predict chem- vival data of the last follow-up survivors were recorded oresistance in ovarian cancer. DNA methylation as a bio- as censored data. PFS (progression-free survival) was marker has the following advantages: chemical stability, defned as the time from initial treatment to tumor pro- quantitative detection, chemoresistance-related methyla- gression. Response to treatment was evaluated using the tion changes usually occur before the start of chemore- Response Evaluation Criteria In Solid Tumors (RECIST sistance, noninvasive detection (can be detected in the 1.1 criteria) [19]. Platinum-resistant and refractory ovar- patient’s body fuids) [7]. With the update of DNA meth- ian cancer was defned as those whose disease had pro- ylation detection platform and technology, more and gressed during frst-line platinum-based chemotherapy more genes involved in ovarian cancer chemoresistance or relapsed within 6 months after the last platinum treat- have been reported. Except BRCA1, DNA damage repair ment [20]. Platinum-sensitive ovarian cancer was defned pathway-related genes, PTEN, RASSF1, MDR1 and as relapse more than 6 months after platinum-based FANCF gene hypermethylation were positively corre- chemotherapy [21]. lated with chemotherapy sensitivity. In recent years, new DNA methylation studies related to chemotherapy resist- ance of ovarian cancer include at least MLH1 [8], SER- Study design PINE1 [9], TRIB2 [10], KLF4 [11], FZD10 [12], ZNF671 In this study, we included two stages to identify and [13], ABCB1 [14], hMSH2 [15] and other genes. Tis validate chemoresistance-related CpGs in ovarian can- shows that the regulatory mechanism of DNA methyla- cer. In the discovery stage, 450 K Infnium Methylation tion in ovarian cancer chemotherapy resistance is com- BeadChip was used for screening, and enrichment anal- plex and diverse. A variety of methylated genes interact ysis was used to select biologically meaningful CpGs. with each other, which together leads to chemotherapy Te relationship between abnormal methylation and resistance in ovarian cancer. chemotherapy resistance and prognosis was analyzed. Relative to genetic mutations, DNA methylation can In the verifcation stage, candidate CpGs were verifed be reversed. Demethylation drugs can reverse abnormal by pyrosequencing. To clarify whether diferential CpGs methylation, improve the sensitivity of ovarian cancer play a biological function, we used QRT-PCR and immu- patients to chemotherapy drugs, improve efcacy and nohistochemistry to detect gene expression. prolong survival [16–18]. Currently, there are few results on genome-wide methylation in chemoresistant ovarian cancer patients. Here, we used 450 K Infnium Methyla- 450K Infnium Methylation BeadChip tion BeadChip to study the genome-wide methylation Qualifed DNA was extracted from 108 samples. DNA characteristics of chemotherapy resistance in ovarian was modifed by Epitect bisulfte kit (Qiagen, Cat. No. cancer. 59110, Germany) and analyzed by 450 K Infnium Meth- ylation BeadChip (Illumina, San Diego, CA, USA) in Materials and methods Shanghai Jingneng company. Te methylation level was Patients scored with standardized beta score values ranging from We collected the initial surgical samples of ovarian can- 0 (unmethylated) to 1 (fully methylated). Limma pack- cer patients (only carcinomas and not borderline tumors) age (R) calculates diferential methylation sites between from the Guangxi Medical University Cancer Hospital. chemotherapy-resistant and chemotherapy-sensitive A total of 108 frozen samples (epithelial ovarian cancer) patients (P ≤ 0.01, |Dif Beta Score| ≥ 0.1). Go (http:// were used for 450 K Infnium Methylation BeadChip, geneo ntolo gy. org/) and KEGG (http:// www. genome. pyrosequencing and QRT-PCR. 132 parafn samples jp/ kegg/) databases were used to enrich the diferential (advanced high-grade serous ovarian carcinoma) were methylation genes. Te candidate CpGs were selected used for immunohistochemistry. All patients had com- according to the Dif Beta Score value and biological plete chemotherapy outcome records and postoperative function. Feng et al. Clin Epigenet (2021) 13:141 Page 3 of 18 Literature search strategy low expression, while > 6 points were classifed as a high Gene search strategies were based on Yan’s article [22]. expression [23]. Used ‘ovarian cancer’ or ‘ovarian carcinoma,’ ‘DNA methylation’ or ‘methylation,’ ‘resistant’ or ‘resistance’ Statistical analysis or ‘chemoresistance’ as keywords, we screened methyl-
Load more

Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
    [Show full text]
  • Supplementary Table 1.Xlsx
    SUPPLEMENTARY APPENDIX Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype Frank G. Rücker, 1 Anna Dolnik, 1 Tamara J. Blätte, 1 Veronica Teleanu, 1 Aurélie Ernst, 2 Felicitas Thol, 3 Michael Heuser, 3 Arnold Ganser, 3 Hartmut Döhner, 1 Konstanze Döhner *1 and Lars Bullinger *1,4 1Department of Internal Medicine III, University Hospital of Ulm, Albert-Einstein-Allee 23; 2Division of Molecular Genetics, German Cancer Consor - tium (DKTK), German Cancer Research Center (DKFZ), Heidelberg; 3Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplanta - tion, Hannover Medical School and 4Department of Hematology, Oncology and Tumor Immunology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany *KD and LB contributed equally to this work. Correspondence: [email protected] doi:10.3324/haematol.2017.180497 Supplementary Table 1 Top 200 differentially expressed genes in chromothripsis‐positive (n=13) vs –negative (n=14) CK‐AML (p‐value <.05) Symbol ID LogFC p value PSMB10 5699 ‐1,652 4,81E‐05 ADAMTS6 11174 ‐1,736 1,50E‐04 SLC7A6 9057 ‐1,317 6,80E‐04 VANGL1 81839 2,403 6,94E‐04 ZNF197 10168 1,409 7,30E‐04 TAS2R62P 338399 ‐1,404 9,22E‐04 PLA2G15 23659 ‐1,455 0,001 CBFB 865 ‐1,453 0,001 CNOT8 9337 ‐1,449 0,001 ACD 65057 ‐1,329 0,001 CKLF 51192 ‐1,657 0,002 CMTM3 123920 ‐1,48 0,002 FAM192A 80011 ‐1,408 0,002 SSH3 54961 ‐1,279 0,002 ZNF415 55786 1,425 0,002 BEX2 84707 1,57 0,002 GCNT2 2651 1,732 0,002 PIM1 5292 1,935
    [Show full text]
  • An Evolutionary Based Strategy for Predicting Rational Mutations in G Protein-Coupled Receptors
    Ecology and Evolutionary Biology 2021; 6(3): 53-77 http://www.sciencepublishinggroup.com/j/eeb doi: 10.11648/j.eeb.20210603.11 ISSN: 2575-3789 (Print); ISSN: 2575-3762 (Online) An Evolutionary Based Strategy for Predicting Rational Mutations in G Protein-Coupled Receptors Miguel Angel Fuertes*, Carlos Alonso Department of Microbiology, Centre for Molecular Biology “Severo Ochoa”, Spanish National Research Council and Autonomous University, Madrid, Spain Email address: *Corresponding author To cite this article: Miguel Angel Fuertes, Carlos Alonso. An Evolutionary Based Strategy for Predicting Rational Mutations in G Protein-Coupled Receptors. Ecology and Evolutionary Biology. Vol. 6, No. 3, 2021, pp. 53-77. doi: 10.11648/j.eeb.20210603.11 Received: April 24, 2021; Accepted: May 11, 2021; Published: July 13, 2021 Abstract: Capturing conserved patterns in genes and proteins is important for inferring phenotype prediction and evolutionary analysis. The study is focused on the conserved patterns of the G protein-coupled receptors, an important superfamily of receptors. Olfactory receptors represent more than 2% of our genome and constitute the largest family of G protein-coupled receptors, a key class of drug targets. As no crystallographic structures are available, mechanistic studies rely on the use of molecular dynamic modelling combined with site-directed mutagenesis data. In this paper, we hypothesized that human-mouse orthologs coding for G protein-coupled receptors maintain, at speciation events, shared compositional structures independent, to some extent, of their percent identity as reveals a method based in the categorization of nucleotide triplets by their gross composition. The data support the consistency of the hypothesis, showing in ortholog G protein-coupled receptors the presence of emergent shared compositional structures preserved at speciation events.
    [Show full text]
  • Research Article the Differentially Expressed
    Ashdin Publishing Journal of Drug and Alcohol Research Vol. 10 (2021), Article ID 236125, 5 pages Research Article The Differentially Expressed Genes and Biomarker Identification for Dengue Disease Using Transcriptome Data Analysis Sunil Krishnan G, Amit Joshi and Vikas Kaushik* Department of Bioinformatics, Lovely Professional University, Punjab, India *Address Correspondence to: Vikas Kaushik, Department of Bioinformatics, Lovely Professional University, Punjab, India, E-mail: [email protected] Received: May 24, 2021; Accepted: June 07, 2021; Published: June 14, 2021 Copyright © 2021 Sunil Krishnan G. This is an open access article distributed under the terms of the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract [9]. Several microarray studies acknowledged differential- This bioinformatics and biostatistics study was designed to recognize and ly expressed genes (DEGs) from multiple sample profiles examine the differentially expressed genes (DEGs) linked with dengue vi- [10,11]. Consistently DEGs identified from various previ- rus infection in Homo sapiens. Thirty nine transcriptome profile datasets ous studies [12-16] were used to make out a potential bio- were analyzed by linear models for microarray analysis based on the R package of the biostatistics test for the identification of significantly ex- marker for the DENV disease. Meta-analysis approaches pressed genes associated with the disease. The Benjamini and Hochberg are common practice to discover novel DEG signatures for (BH) standard operating procedure assessed DEGs had the least false dis- superior biomarkers and synthetic/biotherapeutics [17,18]. covery rate and chosen for further bioinformatics gene analysis.
    [Show full text]
  • Differentially Methylated Genes
    10/30/2013 Disclosures Key Rheumatoid Arthritis-Associated Pathogenic Pathways Revealed by Integrative Analysis of RA Omics Datasets Consultant: IGNYTA Funding: Rheumatology Research Foundation By John W. Whitaker, Wei Wang and Gary S. Firestein DNA methylation and gene regulation The RA methylation signature in FLS DNA methylation – DNMT1 (maintaining methylation) OA – DNMT3a, 3b (de novo methylation) RA % of CpG methylation: 0% 100% Nakano et al. 2013 ARD AA06 AANAT AARS ABCA6 ABCC12 ABCG1 ABHD8 ABL2 ABR ABRA ACACA ACAN ACAP3 ACCSL ACN9 ACOT7 ACOX2 ACP5 ACP6 ACPP ACSL1 ACSL3 ACSM5 ACVRL1 ADAM10 ADAM32 ADAM33 ADAMTS12 ADAMTS15 ADAMTS19 ADAMTS4 ADAT3 ADCK4 ADCK5 ADCY2 ADCY3 ADCY6 ADORA1 ADPGK ADPRHL1 ADTRP AFAP1 AFAP1L2 AFF3 AFG3L1P AGAP11 AGER AGTR1 AGXT AIF1L AIM2 AIRE AJUBA AK4 AKAP12 AKAP2 AKR1C2 AKR1E2 AKT2 ALAS1 ALDH1L1-AS1 ALDH3A1 ALDH3B1 ALDH8A1 ALDOB ALDOC ALOX12 ALPK3 ALS2CL ALX4 AMBRA1 AMPD2 AMPD3 ANGPT1 ANGPT2 ANGPTL5 ANGPTL6 ANK1 ANKMY2 ANKRD29 ANKRD37 ANKRD53 ANO3 ANO6 ANO7 ANP32C ANXA6 ANXA8L2 AP1G1 AP2A2 AP2M1 AP5B1 APBA2 APC APCDD1 APOBEC3B APOBEC3G APOC1 APOH APOL6 APOLD1 APOM AQP1 AQP10 AQP6 AQP9 ARAP1 ARHGAP24 ARHGAP42 ARHGEF19 ARHGEF25 ARHGEF3 ARHGEF37 ARHGEF7 ARL4C ARL6IP 5 ARL8B ARMC3 ARNTL2 ARPP21 ARRB1 ARSI ASAH2B ASB10 ASB2 ASCL2 ASIC4 ASPH ATF3 ATF7 ATL1 ATL3 ATP10A ATP1A1 ATP1A4 ATP2C1 ATP5A1 ATP5EP2 ATP5L2 ATP6V0CP3 ATP6V1C1 ATP6V1E2 ATXN7L1 ATXN7L2 AVPI1 AXIN2 B3GNT7 B3GNT8 B3GNTL1 BACH1 BAG3 Differential methylated genes in RA FLS BAIAP2L2 BANP BATF BATF2 BBS2 BCAS4 BCAT1 BCL7C BDKRB2 BEGAIN BEST1 BEST3
    [Show full text]
  • Sex-Specific Transcriptome Differences in Human Adipose
    G C A T T A C G G C A T genes Article Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells 1, 2, 3 1,3 Eva Bianconi y, Raffaella Casadei y , Flavia Frabetti , Carlo Ventura , Federica Facchin 1,3,* and Silvia Canaider 1,3 1 National Laboratory of Molecular Biology and Stem Cell Bioengineering of the National Institute of Biostructures and Biosystems (NIBB)—Eldor Lab, at the Innovation Accelerator, CNR, Via Piero Gobetti 101, 40129 Bologna, Italy; [email protected] (E.B.); [email protected] (C.V.); [email protected] (S.C.) 2 Department for Life Quality Studies (QuVi), University of Bologna, Corso D’Augusto 237, 47921 Rimini, Italy; [email protected] 3 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Via Massarenti 9, 40138 Bologna, Italy; fl[email protected] * Correspondence: [email protected]; Tel.: +39-051-2094114 These authors contributed equally to this work. y Received: 1 July 2020; Accepted: 6 August 2020; Published: 8 August 2020 Abstract: In humans, sexual dimorphism can manifest in many ways and it is widely studied in several knowledge fields. It is increasing the evidence that also cells differ according to sex, a correlation still little studied and poorly considered when cells are used in scientific research. Specifically, our interest is on the sex-related dimorphism on the human mesenchymal stem cells (hMSCs) transcriptome. A systematic meta-analysis of hMSC microarrays was performed by using the Transcriptome Mapper (TRAM) software. This bioinformatic tool was used to integrate and normalize datasets from multiple sources and allowed us to highlight chromosomal segments and genes differently expressed in hMSCs derived from adipose tissue (hADSCs) of male and female donors.
    [Show full text]
  • WO 2019/068007 Al Figure 2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/068007 Al 04 April 2019 (04.04.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors; and C12N 15/10 (2006.01) C07K 16/28 (2006.01) (71) Applicants: GROSS, Gideon [EVIL]; IE-1-5 Address C12N 5/10 (2006.0 1) C12Q 1/6809 (20 18.0 1) M.P. Korazim, 1292200 Moshav Almagor (IL). GIBSON, C07K 14/705 (2006.01) A61P 35/00 (2006.01) Will [US/US]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., C07K 14/725 (2006.01) P.O. Box 4044, 7403635 Ness Ziona (TL). DAHARY, Dvir [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (21) International Application Number: Box 4044, 7403635 Ness Ziona (IL). BEIMAN, Merav PCT/US2018/053583 [EilL]; c/o ImmPACT-Bio Ltd., 2 Ilian Ramon St., P.O. (22) International Filing Date: Box 4044, 7403635 Ness Ziona (E.). 28 September 2018 (28.09.2018) (74) Agent: MACDOUGALL, Christina, A. et al; Morgan, (25) Filing Language: English Lewis & Bockius LLP, One Market, Spear Tower, SanFran- cisco, CA 94105 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 62/564,454 28 September 2017 (28.09.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/649,429 28 March 2018 (28.03.2018) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (71) Applicant: IMMP ACT-BIO LTD.
    [Show full text]
  • Olfactory Receptors in Non-Chemosensory Tissues
    BMB Reports Invited Mini Review Olfactory receptors in non-chemosensory tissues NaNa Kang & JaeHyung Koo* Department of Brain Science, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 711-873, Korea Olfactory receptors (ORs) detect volatile chemicals that lead to freezing behavior (3-5). the initial perception of smell in the brain. The olfactory re- ORs are localized in the cilia of olfactory sensory neurons ceptor (OR) is the first protein that recognizes odorants in the (OSNs) in the olfactory epithelium (OE) and are activated by olfactory signal pathway and it is present in over 1,000 genes chemical cues, typically odorants at the molecular level, in mice. It is also the largest member of the G protein-coupled which lead to the perception of smell in the brain (6). receptors (GPCRs). Most ORs are extensively expressed in the Tremendous research was conducted since Buck and Axel iso- nasal olfactory epithelium where they perform the appropriate lated ORs as an OE-specific expression in 1991 (7). OR genes, physiological functions that fit their location. However, recent the largest family among the G protein-coupled receptors whole-genome sequencing shows that ORs have been found (GPCRs) (8), constitute more than 1,000 genes on the mouse outside of the olfactory system, suggesting that ORs may play chromosome (9, 10) and more than 450 genes in the human an important role in the ectopic expression of non-chemo- genome (11, 12). sensory tissues. The ectopic expressions of ORs and their phys- Odorant activation shows a distinct signal transduction iological functions have attracted more attention recently since pathway for odorant perception.
    [Show full text]
  • Sean Raspet – Molecules
    1. Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Molecular weight: 240.39 g/mol Volume (cubic Angstroems): 258.88 Atoms number (non-hydrogen): 17 miLogP: 4.43 Structure: Biological Properties: Predicted Druglikenessi: GPCR ligand -0.23 Ion channel modulator -0.03 Kinase inhibitor -0.6 Nuclear receptor ligand 0.15 Protease inhibitor -0.28 Enzyme inhibitor 0.15 Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Predicted Olfactory Receptor Activityii: OR2L13 83.715% OR1G1 82.761% OR10J5 80.569% OR2W1 78.180% OR7A2 77.696% 2. Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Molecular weight: 239.36 Volume (cubic Angstroems): 252.83 Atoms number (non-hydrogen): 17 miLogP: 4.33 Structure: Biological Properties: Predicted Druglikeness: GPCR ligand -0.6 Ion channel modulator -0.41 Kinase inhibitor -0.93 Nuclear receptor ligand -0.17 Protease inhibitor -0.39 Enzyme inhibitor 0.01 Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Predicted Olfactory Receptor Activity: OR52D1 71.900% OR1G1 70.394% 0R52I2 70.392% OR52I1 70.390% OR2Y1 70.378% 3. Commercial name: Hyperflor© IUPAC Name: 2-benzyl-1,3-dioxan-5-one SMILES: O=C1COC(CC2=CC=CC=C2)OC1 Molecular weight: 192.21 g/mol Volume
    [Show full text]
  • Genetic Characterization of Greek Population Isolates Reveals Strong Genetic Drift at Missense and Trait-Associated Variants
    ARTICLE Received 22 Apr 2014 | Accepted 22 Sep 2014 | Published 6 Nov 2014 DOI: 10.1038/ncomms6345 OPEN Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variants Kalliope Panoutsopoulou1,*, Konstantinos Hatzikotoulas1,*, Dionysia Kiara Xifara2,3, Vincenza Colonna4, Aliki-Eleni Farmaki5, Graham R.S. Ritchie1,6, Lorraine Southam1,2, Arthur Gilly1, Ioanna Tachmazidou1, Segun Fatumo1,7,8, Angela Matchan1, Nigel W. Rayner1,2,9, Ioanna Ntalla5,10, Massimo Mezzavilla1,11, Yuan Chen1, Chrysoula Kiagiadaki12, Eleni Zengini13,14, Vasiliki Mamakou13,15, Antonis Athanasiadis16, Margarita Giannakopoulou17, Vassiliki-Eirini Kariakli5, Rebecca N. Nsubuga18, Alex Karabarinde18, Manjinder Sandhu1,8, Gil McVean2, Chris Tyler-Smith1, Emmanouil Tsafantakis12, Maria Karaleftheri16, Yali Xue1, George Dedoussis5 & Eleftheria Zeggini1 Isolated populations are emerging as a powerful study design in the search for low-frequency and rare variant associations with complex phenotypes. Here we genotype 2,296 samples from two isolated Greek populations, the Pomak villages (HELIC-Pomak) in the North of Greece and the Mylopotamos villages (HELIC-MANOLIS) in Crete. We compare their genomic characteristics to the general Greek population and establish them as genetic isolates. In the MANOLIS cohort, we observe an enrichment of missense variants among the variants that have drifted up in frequency by more than fivefold. In the Pomak cohort, we find novel associations at variants on chr11p15.4 showing large allele frequency increases (from 0.2% in the general Greek population to 4.6% in the isolate) with haematological traits, for example, with mean corpuscular volume (rs7116019, P ¼ 2.3 Â 10 À 26). We replicate this association in a second set of Pomak samples (combined P ¼ 2.0 Â 10 À 36).
    [Show full text]
  • Get High-Res Image
    150 100 50 163 169 313 # mutations Non syn. Syn. E">)->(A/T: E">6A/C/T)->(A/T) flip A->6";): indel+null double_null # mutations/Mb 0 20 40 60 80 2% 6% 4% 5% 1% 3% 3% 5% 4% 1% 3% 2% 10% 8% 5% 2% 3% 5% 7% 2% 4% 1% 5% 2% 4% 4% 6% 4% 5% 2% 2% 5% 4% 3% 6% 3% 17% 2% 1% 1% 6% 3% 1% 4% 1% 2% 3% 8% 2% 2% 5% 3% 2% 1% 6% 5% 2% 2% 4% 3% 6% 3% 1% 3% 3% 5% 1% 4% 2% 0% 5% 3% 5% 4% 1% 3% 15% 4% 2% 10% 7% 7% 3% 10% 3% 6% 4% 3% 11% 4% 3% 6% 21% 3% 3% 4% 8% 2% 6% 5% 4% 8% 3% 3% 6% 1% 6% 3% 2% 5% 7% 5% 3% 3% 2% 10% 3% 17% 6% 6% 4% 6% 12% 9% 5% 6% 5% 4% 3% 2% 21% 5% 4% 4% 17% 5% 3% 4% 3% 4% 4% 7% 7% 6% 6% 6% 4% 6% 6% 6% 8% 6% 1% 2% 2% 2% 3% 4% 8% 13% 17% 30% 54% 15% 0 (0A$205243952TP (0A$297281792TP(0A$273246702TP (0A$299280252TP(0A$255282992TP (0A$2MP2A4T&2TP(0A$250259392TP (0A$205254252TP(0A$244267792TP (0A$255279132TP(0A$275251462TP (0A$2622A4712TP(0A$255275742TP (0A$205244322TP(0A$244281202TP (0A$2442A4792TP(0A$249244872TP (0A$2N-2A4'&2TP(0A$286282802TP (0A$278275352TP(0A$255215962TP (0A$235236152TP(0A$244261442TP (0A$2N-2A55!2TP(0A$278271662TP (0A$244267762TP(0A$244276712TP (0A$2-2281942TP(0A$267237742TP (0A$2N-2A4'P2TP(0A$255282032TP (0A$205244172TP(0A$255285082TP (0A$286283592TP(0A$286277132TP (0A$2MP2A4TE2TP(0A$280256082TP (0A$299280322TP(0A$255286152TP (0A$2622A46S2TP(0A$250259322TP (0A$2N-2A55*2TP(0A$278271612TP (0A$2952A4VP2TP(0A$249245072TP (0A$249244862TP(0A$291268492TP (0A$2622A46P2TP(0A$2622A4702TP (0A$205244222TP(0A$250250722TP (0A$2MP2A4TH2TP(0A$275270312TP (0A$299280332TP(0A$255280942TP (0A$295270392TP(0A$255283022TP (0A$249245052TP(0A$293280672TP
    [Show full text]
  • A Genetic Variant Near Olfactory Receptor Genes Influences Cilantro Preference
    A genetic variant near olfactory receptor genes influences cilantro preference Nicholas Eriksson1,*, Shirley Wu1, Chuong B. Do1, Amy K. Kiefer1, Joyce Y. Tung1, Joanna L. Mountain1, David A. Hinds1, and Uta Francke1 123andMe, Inc., Mountain View, CA USA *[email protected] September 11, 2012 Abstract ponent to cilantro taste perception and suggest that cilantro dislike may stem from genetic variants in ol- The leaves of the Coriandrum sativum plant, known factory receptors. We propose that OR6A2 may be as cilantro or coriander, are widely used in many the olfactory receptor that contributes to the detec- cuisines around the world. However, far from being tion of a soapy smell from cilantro in European pop- a benign culinary herb, cilantro can be polarizing| ulations. many people love it while others claim that it tastes or smells foul, often like soap or dirt. This soapy or pungent aroma is largely attributed to several Background aldehydes present in cilantro. Cilantro preference is suspected to have a genetic component, yet to date The Coriandrum sativum plant has been cultivated nothing is known about specific mechanisms. Here since at least the 2nd millennium BCE [1]. Its fruits we present the results of a genome-wide association (commonly called coriander seeds) and leaves (called study among 14,604 participants of European ances- cilantro or coriander) are important components of try who reported whether cilantro tasted soapy, with many cuisines. In particular, South Asian cuisines replication in a distinct set of 11,851 participants who use both the leaves and the seeds prominently, and declared whether they liked cilantro.
    [Show full text]